Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human adipose-derived mesenchymal stem cells for injection
- Development stage
- Phase 2
- Lead developer
- Beijing Aige Stem Cell Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intralesional
01
Overview
Human adipose-derived mesenchymal stem cells for injection (developed under code names AG1001, AG1002, and AG2001) is an allogeneic, standardized stem cell therapy developed by Beijing Aige Stem Cell Technology. The therapy utilizes mesenchymal stem cells isolated and expanded from the adipose tissue of healthy donors. These cells possess multi-lineage differentiation potential and secrete a variety of bioactive factors that mediate immunomodulatory, anti-inflammatory, anti-fibrotic, and pro-angiogenic effects. It is being evaluated in clinical trials for the treatment of hand skin lesions in systemic sclerosis (AG1001), localized scleroderma (AG1002), and diabetic foot ulcers (AG2001).
- Other names
- 人脂肪间充质干细胞注射液
Beyond the preview
Go deeper on human adipose-derived mesenchymal stem cells for injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human adipose-derived mesenchymal stem cells for injection.